AIQ Global Inc.
Madison, WI Doing business as AIQ Solutions
- UEI
- WGMJSUUQ3L35
- CAGE
- 7Y1R7
- Primary NAICS
- 541512 Computer Systems Design Services
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 8000 Excelsior Dr #400, Madison, WI 53717, USA
- Website
- aiq-solutions.com
- Founded
- 2016
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Comprehensive assessment of cancer theranostics response | National Cancer Institute (NIH) | $3,090,107 | |
| Comprehensive assessment of cancer immunotherapy response | National Cancer Institute (NIH) | $3,003,277 | |
| Comprehensive assessment of cancer immunotherapy response | National Cancer Institute (NIH) | $388,323 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Imaging Biometrics, LLC | Elm Grove, WI | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
| Vizlitics Inc. | Chappaqua, NY | 513210 Software Publishers |
| Quantitative Imaging Systems LLC | Pittsburgh, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Cortechs Al | San Diego, CA | — |
| Visage Imaging, Inc. | San Diego, CA | 513210 Software Publishers |
About the company
AIQ Global Inc., doing business as AIQ Solutions, is a corporate entity registered to receive federal grant awards from U.S. government agencies. The company develops AI-powered software solutions for healthcare applications, particularly focused on cancer diagnosis, treatment monitoring, and response assessment.
Through prime federal grant awards from the National Institutes of Health (NIH) National Cancer Institute, AIQ Solutions has developed novel software products like TRAQINFORM Theranostics and TRAQINFORM Immuno. TRAQINFORM Theranostics is an AI-based software designed for comprehensive spatio-temporal analysis of theranostic response in cancer patients, including quantifying target receptor status, predicting treatment efficacy and response for all tumor lesions, and quantifying and predicting treatment-related toxicities in critical organs. The software aims to improve clinical outcomes, quality of life, and reduce therapy costs for patients with advanced malignancies, particularly metastatic castration-resistant prostate cancer. TRAQINFORM Immuno, on the other hand, is a software platform for comprehensive assessment of cancer immunotherapy response, quantifying treatment effectiveness in all lesions, immune-related toxicities in critical organs, and calculating the probability of achieving optimal clinical effectiveness and immune-related adverse events. These software solutions are intended to provide clinicians and researchers with actionable, quantitative, and clinically relevant decision-making data to optimize patient management in cancer immunotherapy.
Quick answers
Is AIQ Global Inc. registered in SAM.gov?
Yes. AIQ Global Inc.'s SAM.gov registration is active through November 10, 2026.
What is AIQ Global Inc.'s most recent federal award?
AIQ Global Inc.'s most recent federal grant award is Comprehensive assessment of cancer theranostics response (R44CA285006), from National Cancer Institute (NIH), on September 22, 2023.
On GovTribe
See AIQ Global Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors